| Report ID | 283048 |
| Drug Identification Number | 02421445 |
| Brand name | DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS USP 28 |
| Common or Proper name | Yaz |
| Company Name | GLENMARK PHARMACEUTICALS CANADA INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | DROSPIRENONE ETHINYL ESTRADIOL |
| Strength(s) | 3MG 0.03MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 28 |
| ATC code | G03AA |
| ATC description | HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2026-04-16 |
| Actual start date | |
| Estimated end date | 2026-05-15 |
| Actual end date | |
| Shortage status | Anticipated shortage |
| Updated date | 2026-04-16 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1600 STEELES AVE. W., SUITE 407 CONCORD, ONTARIO CANADA L4K 4M2 |
| Company contact information |
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2026-04-16 | French | Compare |
| v1 | 2026-04-16 | English | Compare |
Showing 1 to 2 of 2